Ana Garcia
About me
Ana García Álvarez is an Associate Professor at the University of Barcelona and Head of the Cardiology Department at the Hospital Clínic of Barcelona. She is specialized in advanced cardiac imaging (Mount Sinai Hospital, New York), statistics and research methodology (Master's degree from the Autonomous University of Barcelona and Johns Hopkins University, Baltimore), and preclinical experimentation (researcher at IDIBAPS and the National Center for Cardiovascular Research). Her research focuses on the study of cardiomyopathies, heart failure, and associated pulmonary hypertension, from a translational perspective
Featured publications
-
Influence of Subclinical Atherosclerosis Burden and Progression on Mortality
Authors:Reference: Journal Of The American College Of Cardiology 2024. -
Unidirectional association of clonal hematopoiesis with atherosclerosis development
Authors:Reference: Nature Medicine 2024. -
Metabolic changes contribute to maladaptive right ventricular hypertrophy in pulmonary hypertension beyond pressure overload: an integrative imaging and omics investigation
Authors:Reference: Basic Research In Cardiology 2024. -
β3-adrenergic agonist treatment in chronic pulmonary hypertension associated with heart failure (SPHERE-HF): a double blind, placebo-controlled, randomized clinical trial
Authors:Reference: European Journal Of Heart Failure 2023. -
Effect of pulmonary artery denervation in postcapillary pulmonary hypertension: results of a randomized controlled translational study
Authors:Reference: Basic Research In Cardiology 2019. -
Magnetic Resonance Characterization of Cardiac Adaptation and Myocardial Fibrosis in Pulmonary Hypertension Secondary to Systemic-To-Pulmonary Shunt
Authors:Reference: Circulation-Cardiovascular Imaging 2016. -
Beta-3 adrenergic agonists reduce pulmonary vascular resistance and improve right ventricular performance in a porcine model of chronic pulmonary hypertension
Authors:Reference: Basic Research In Cardiology 2016. -
Association of myocardial T1-mapping CMR with hemodynamics and RV performance in pulmonary hypertension
Authors:Reference: Jacc-Cardiovascular Imaging 2015. -
Noninvasive monitoring of serial changes in pulmonary vascular resistance and acute vasodilator testing using cardiac magnetic resonance
Authors:Reference: Journal Of The American College Of Cardiology 2013. -
Non-invasive estimation of pulmonary vascular resistance with cardiac magnetic resonance
Authors:Reference: European Heart Journal 2011.
Featured Projects
-
A blueprint of inflammation in human atherosclerosis
Principal investigator: Ana García Alvarez, Ana García ÁlvarezFunder: Hospital Clinic de Barcelona (Sede o evento); Fundació La Marató de TV3Code: 202314 30 31Duration: 01/01/2024 - 01/01/2027 -
Papel del metabolismo en la adaptación del ventrículo derecho en la hipertensión pulmonar: efecto de la empagliflozina y monitorización in-vivo con PET-FDG y espectrometría por resonancia magnética
Principal investigator: Ana García Alvarez, Ana García ÁlvarezFunder: Hospital Clinic de Barcelona (Sede o evento); Instituto de Salud Carlos III ; Fondo de Investigaciones Sanitarias (FIS) (Programa financiador competitivo)Code: PI23/01341Duration: 01/01/2024 - 01/01/2027 -
Integrative clinical, imaging and omics phenotyping of right ventricular-pulmonary circulation function in pulmonary hypertension secondary to heart failure: moving towards the identification and evaluation of therapeutic targets
Principal investigator: Ana García Alvarez, Ana García ÁlvarezFunder: Hospital Clinic de Barcelona (Sede o evento); Instituto de Salud Carlos III ; Proyectos FIS (Programa financiador competitivo)Code: PI20/00742Duration: 01/01/2021 - 01/01/2024 -
Estudio de los mecanismos fisiopatológicos que conducen a la hipertrofia maladaptativa del ventrículo derecho en la hipertensión pulmonar crónica.
Principal investigator: Ana García Alvarez, Ana García ÁlvarezFunder: Hospital Clínic y Provincial de Barcelona (Sede o evento); Instituto de Salud Carlos III ; Proyectos FIS (Programa financiador competitivo)Code: PI17/00995Duration: 01/01/2018 - 01/01/2021 -
Tractament agonista B3 adrenèrgic en la hipertensió pulmonar crònica secundària a insuficiència cardíaca: assaig clínic fase 2 aleatoritzat i controlat amb placebo. Projecte de la FUNDACIO LA MARATÓ DE TV3
Principal investigator: Ana García Alvarez, Ana García ÁlvarezFunder: HOSPITAL CLINICO Y PROVINCIAL DE BARCELONA (Sede o evento); Fundació La Marató de TV3 ; Proyectos La Marató de TV3 (Programa financiador competitivo)Code: 20151730-31-32Duration: 01/01/2016 - 01/01/2019